Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial

Abstract Objective Aspirin (acetylsalicylic acid, ASA) and rivaroxaban are anticoagulants that have increased in popularity due to ease of use in the prevention of venous thromboembolism (VTE) after total knee arthroplasty (TKA). The present study aimed to evaluate the efficacy of ASA compared with...

Full description

Bibliographic Details
Published in:	Revista Brasileira de Ortopedia
Main Authors:	Theerawit Hongnaparak, Jiranuwat Janejaturanon, Khanin Iamthanaporn, Pramot Tanutit, Varah Yuenyongviwat
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2022-11-01
Subjects:	aspirin rivaroxaban arthroplasty, replacement, knee venous thromboembolism
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-36162022000500741&lng=en&tlng=en

Similar Items

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
by: Kochawan Boonyawat, et al.
Published: (2021-02-01)

Aspirin is Not for Everyone: Discharge to Non-home Facilities After Total Hip and Knee Arthroplasty Increases Risk of Venous Thromboembolism
by: Michael McHugh, MD, et al.
Published: (2024-06-01)

The Efficacy of Topical Tranexamic Acid in Femoral Neck Fractured Patients Undergoing Cemented Bipolar Hemiarthroplasty: A Randomized Double Blinded Controlled Trial
by: Theerawit Hongnaparak, et al.
Published: (2023-08-01)

Which orally administered antithrombotic agent is most effective for preventing venous thromboembolism after total knee arthroplasty? A propensity score-matching analysis
by: Seonpyo Jang, et al.
Published: (2021-03-01)

Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE
by: Norikazu Yamada, et al.
Published: (2024-06-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
by: Victoria Speed, et al.
Published: (2021-12-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-08-01)

Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
by: Zhuang Liu, et al.
Published: (2023-04-01)

Comparative evaluation of enoxaparin and rivaroxaban treatment outcomes in cancer patients with venous thromboembolism: a prospective cohort study
by: Mostafa Kamandi, et al.
Published: (2025-07-01)

Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study
by: Li-Bo Zhou, et al.
Published: (2023-01-01)

Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
by: Sara Reda, et al.
Published: (2022-05-01)

Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience
by: Gerald A. Soff, et al.
Published: (2019-07-01)

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
by: Stephanie Müller, et al.
Published: (2022-10-01)

Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study
by: Verinder Sidhu, et al.
Published: (2023-08-01)

Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
by: Ikuo Fukuda, et al.
Published: (2021-10-01)

Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01)

Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
by: Ho-Young Yhim, et al.
Published: (2019-09-01)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
by: Caroti Caroti, et al.
Published: (2023-07-01)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)

THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
by: Cristiano Bortoluzzi, et al.
Published: (2022-10-01)

Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
by: Xiaofeng Zheng, et al.
Published: (2025-05-01)

Clinical characteristics and dosing of apixaban and rivaroxaban for the management of venous thromboembolism: A multi-center retrospective observational study
by: Majed S. Al Yami, et al.
Published: (2023-08-01)

Adjuvant therapeutic efficacy of low-dose aspirin on short-term outcomes of patients with cancer-associated venous thromboembolism
by: Wei Xiong, et al.
Published: (2025-07-01)

Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study
by: Wang C, et al.
Published: (2024-06-01)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
by: Maha Al-Ghafry, et al.
Published: (2022-10-01)

Aspirin for the extended prevention of venous thromboembolism: a meta-analysis and trial sequential analysis
by: Michele Carron, et al.
Published: (2025-05-01)

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study
by: Anthonie W. A. Lensing, et al.
Published: (2018-12-01)

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations
by: Cyril Leven, et al.
Published: (2023-02-01)

Venous Thromboembolism and Risk of Cancer in Users of Low-Dose Aspirin: A Danish Population-Based Cohort Study
by: Gencer Kurt, et al.
Published: (2022-07-01)

Efficacy and safety of aspirin in preventing venous thromboembolism after hip arthroplasty for femoral neck fracture: a noninferiority prospective cohort study
by: Yifan Zhang, et al.
Published: (2024-12-01)

Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants
by: Zohreh Gholizadeh Ghozloujeh, et al.
Published: (2025-05-01)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
by: Hamzah Khan, et al.
Published: (2022-08-01)

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness
by: Bin Li, et al.
Published: (2025-09-01)

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
by: Cheng-Ta Wu, et al.
Published: (2018-07-01)

Efficacy of a Combined Intramedullary, Periarticular Injection, and Intraarticular Tranexamic Acid Application on Postoperative Bleeding in Total Knee Arthroplasty: A Retrospective Case-Matched Study
by: Theerawit Hongnaparak, et al.
Published: (2022-01-01)

Effect of different application duration of a venous foot pump on prevention of venous thromboembolism after hip and knee arthroplasty: a multicenter prospective clinical trial
by: Siqi Gu, et al.
Published: (2023-12-01)

A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
by: Hind M. Alosaimi, et al.
Published: (2022-09-01)